ArticleOphthalmology2021
Clinical and Genetic Findings in CTNNA1-Associated Macular Pattern Dystrophy.
Abstract readCase Reports
In one paragraph
Article in Ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Variant-specific functional effects of CTNNA1 in a humanized Drosophila model.European journal of human genetics : EJHG · 2026Article
- Article
- CTNNA1-associated retinal dystrophy: novel multimodal imaging and electrophysiology features.Documenta ophthalmologica. Advances in ophthalmology · 2025Article
- Resolved Central Serous Chorioretinopathy Mimicking Hydroxychloroquine Toxicity: A Case Series and Literature Review.Diagnostics (Basel, Switzerland) · 2025Article
- Next-generation phenotyping of inherited retinal diseases from multimodal imaging with Eye2Gene.Nature machine intelligence · 2025Article
- Mimickers of hydroxychloroquine retinal toxicity.Clinical & experimental ophthalmology · 2024Review
- Current advances and challenges in Managing Hereditary Diffuse Gastric Cancer (HDGC): a narrative review.Hereditary cancer in clinical practice · 2024Review
- α-catenin middle- and actin-binding domain unfolding mutants differentially impact epithelial strength and sheet migration.Molecular biology of the cell · 2024Article
- Epithelial mechanics are maintained by inhibiting cell fusion with age in Drosophila.Journal of cell science · 2023Article
- Frequency ofCancers · 2023Article
- Article
- Bilateral macular drusen in acquired partial lipodystrophy with type 2 membranoproliferative glomerulonephritis.BMJ case reports · 2021Article
- Catenin α 1 mutations cause familial exudative vitreoretinopathy by overactivating Norrin/β-catenin signaling.The Journal of clinical investigation · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Alexander TannerUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Hwei Wuen ChanUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom; Department of Ophthalmology, National University Hospital, Singapore, Republic of Singapore.
Jose S PulidoUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom; Retina Service and Vickie and Jack Farber Vision Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania.
Gavin ArnoUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Rola Ba-AbbadUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Neringa JurkuteUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Anthony G RobsonUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Catherine A EganUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Hannah KnightUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Antonio CalcagniUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Rachel L TaylorManchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester, United Kingdom; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, United Kingdom.
Eva LenassiManchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester, United Kingdom; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, United Kingdom.
Graeme C BlackManchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester, United Kingdom; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, United Kingdom.
Anthony T MooreUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom; Department of Ophthalmology, University of California, San Francisco, School of Medicine, San Francisco, California.
Michel MichaelidesUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Andrew R WebsterUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom.
Omar A MahrooUCL Institute of Ophthalmology, University College London, London, United Kingdom; Moorfields Eye Hospital, London, United Kingdom; Section of Ophthalmology, King's College London, St. Thomas' Hospital, London, United Kingdom; Physiology, Development and Neuroscience, University of Cambridge, Cambridge, United Kingdom. Electronic address: o.mahroo@ucl.ac.uk.
Funding
Medical Research Council MR/R024952/1Wellcome TrustWellcome Trust 206619/Z/17/Z
Abstract
PubMed holds no abstract for this paper.
Indexed as
MutationAdolescentAdultAgedalpha CateninChildChild, PreschoolDNADNA Mutational AnalysisElectroretinographyFemaleHumansMacular DegenerationMaleMiddle AgedPedigreealpha CateninCTNNA1 protein, humanDNAElectrooculographyElectroretinographyMacular degenerationMacular pattern dystrophyRetinaRetinal dystrophies
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.